Summary
Hariprasad Gali is an associate professor and radiopharmaceutical scientist with nine years in academic research leadership and over two decades of technical experience developing PET radiotracers and radionuclide generator materials. He directs a radiochemistry laboratory and a self-shielded 7.5 MeV cyclotron facility, having led CMC development of investigational PET agents compliant with USP <823> for clinical trials. His work spans novel renal PET agents for renography, receptor-targeted peptide therapeutics, and hybrid inorganic-organic ion-exchange materials for 225Ac/213Bi generators, resulting in six U.S. patents, one European patent, and a dozen pending applications. Author of 60+ peer-reviewed papers and presenter at 70+ conferences, he combines hands-on cyclotron/radiochemistry operations with grant-funded translational research and SBIR leadership. Notably, he has translated bench chemistry into regulated clinical materials and on-demand 18F production via an ABT Biomarker Generator, bridging fundamental inorganic materials work with practical clinical imaging solutions.
9 years of coding experience
24 years of employment as a software developer
B. Sc., Mathematics, Physics, Chemistry, B. Sc., Mathematics, Physics, Chemistry at Osmania University
M. Sc., Chemistry, M. Sc., Chemistry at University of Hyderabad
Ph. D, Chemistry, Ph. D, Chemistry at University of Missouri